Viewing Study NCT00526669


Ignite Creation Date: 2025-12-24 @ 10:47 PM
Ignite Modification Date: 2026-02-27 @ 5:38 PM
Study NCT ID: NCT00526669
Status: COMPLETED
Last Update Posted: 2016-01-29
First Post: 2007-09-06
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib
Sponsor: GlaxoSmithKline
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: LPT109747
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators